Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
MarketScreener,
LAVAL, QC and ALPHARETTA, Ga. - Bausch + Lomb, a leading global eye health business of (NYSE/TSX: BHC) (''), and (Nasdaq: CLSD) …